Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Meihua International Medical Technologies CoMHUAF 59 Net Current Asset Value is $185.71 as of Dec. 2025, which is 88333% above its 10-year median of 0.21. GuruFocus rates MHUAF with a GF Score™ of 59/100 and a GF Value™ of $26.50 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 564 Medical Devices & Instruments companies, Meihua International Medical Technologies Co ranks better than 99.82% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
MHUAF'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.01 Med: 0.21 Max: 1.8
Current: 0.05
During the past 7 years, the highest Price-to-Net-Current-Asset-Value Ratio of Meihua International Medical Technologies Co was 1.80. The lowest was 0.01. And the median was 0.21.
MHUAF's Price-to-Net-Current-Asset-Value is ranked better than 99.82% of 564
companies
in the Medical Devices & Instruments industry
Industry Median: 4.905
vs MHUAF: 0.05
Meihua International Medical Technologies Co (OTCPK:MHUAF) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Meihua International Medical Technologies Co Net Current Asset Value Related Terms
Meihua International Medical Technologies Co Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co Net Current Asset Value Chart
Meihua International Medical Technologies Co Annual Data
MHUAF vs CUPR, LUCY, NXGL: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Meihua International Medical Technologies Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meihua International Medical Technologies Co Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Meihua International Medical Technologies Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Meihua International Medical Technologies Co's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $185.71 mean?
Meihua International Medical Technologies Co (MHUAF) has a Net Current Asset Value of $185.71 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Meihua International Medical Technologies Co and its competitors. This is 88333% above median its historical median of 0.21. Over the past decade, Meihua International Medical Technologies Co's Net Current Asset Value has ranged from 0.01 to 1.80. According to the industry distribution chart, Meihua International Medical Technologies Co ranks #1 out of 564 companies in the Medical Devices & Instruments industry, placing it in the top 0.2%.
Is Meihua International Medical Technologies Co's Net Current Asset Value too high?
Meihua International Medical Technologies Co's current Net Current Asset Value of $185.71 is 88333% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 1.80. The Medical Devices & Instruments industry median Net Current Asset Value is 4.91. Meihua International Medical Technologies Co's value of $185.71 is 3686.1% above this industry median. Based on the distribution chart, Meihua International Medical Technologies Co ranks #1 out of 564 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Meihua International Medical Technologies Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meihua International Medical Technologies Co's Net Current Asset Value compare to CUPR and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Meihua International Medical Technologies Co ranks #1 out of 564 companies for Net Current Asset Value. This places Meihua International Medical Technologies Co in the top 0% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 4.91. Meihua International Medical Technologies Co's value of $185.71 is 3686.1% above this benchmark. Historically, Meihua International Medical Technologies Co's own Net Current Asset Value has ranged from 0.01 to 1.80 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 4.91, Meihua International Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.91, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meihua International Medical Technologies Co's current Net Current Asset Value of $185.71 is 3686.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Meihua International Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meihua International Medical Technologies Co's current Net Current Asset Value is $185.71, which is 88333% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihua International Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co (MHUAF) is currently considered Possible Value Trap. The stock's GF Value™ is $26.50, compared to a current price of $8.77 — trading 66.9% below its estimated fair value. The current Net Current Asset Value is $185.71, which is 88333% above median its 10-year median of 0.21 and 3686.1% above the Medical Devices & Instruments industry median of 4.91. Meihua International Medical Technologies Co's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Meihua International Medical Technologies Co (MHUAF), the current Net Current Asset Value is $185.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Meihua International Medical Technologies Co (MHUAF) Overvalued in 2026?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co stock appears to be undervalued.
The current stock price of $8.77 is trading 66.9% below its estimated GF Value™ of $26.50.
GuruFocus considers Meihua International Medical Technologies Co to be Possible Value Trap.
Key valuation signals for MHUAF:
Net Current Asset Value: $185.71 (88333% above median its 10-year median of 0.21)
GF Value™: $26.50 vs. price of $8.77 (66.9% below fair value)
Industry Position: 3686.1% above the Medical Devices & Instruments median (#1 of 564)
No single metric tells the full story. See the MHUAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
59GF Score
Get the complete analysis for MHUAF
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MHUAF has been successfully added to your 
